ResBiotic Raises $3M in Seed Funding

Resbiotic, Inc., a Bilmingham, Ala.-based biotech startup, raised $3M in seed funding.
The round was funded from a private equity syndicate led by Timberline Holdings. Braxton Goodrich (Timberline Holdings) will serve on the ResBiotic Board of Directors.
The company intends to use the funds for the development and commercialization of probiotic formulations for lung health.
ResBiotic is the flagship company of ResBiotech Innovation Institute, founded by physician scientist Dr. C Vivek Lal in 2020. ResBiotic’s first product, a medical food that targets the gut-lung axis, was developed in Dr. Lal’s Pulmonary Microbiome Lab at UAB with research and expertise from the university’s Microbiome Center, Lung Health Center and Translational Research in Normal & Disordered Development (TReNDD) program. The proprietary probiotic blend has been shown to reduce neutrophilic inflammation in individuals with chronic respiratory conditions. The company’s research and development pipeline also includes pharmabiotics for multiple chronic lung diseases.

Related Keywords

Vivek Lal ,Namasivayam Ambalavanan ,Andrew Oconnor ,Scott Bush ,Amit Gaggar ,Braxton Goodrich ,Sanjay Singh ,Microbiome Center ,Resbiotic Inc ,Lal Pulmonary Microbiome Lab ,Resbiotech Innovation Institute ,Timberline Holdings ,Translational Research In Normal Disordered Development Tre ,Harvard University ,Lung Health Center ,Resbiotic Board ,Pulmonary Microbiome Lab ,Translational Research ,Disordered Development ,Executive Vice President ,Casey Morrow ,James Mike Wells ,Scientific Advisory ,Critical Care Medicine ,Chief Medical ,Andrewo Connor ,Chief Operating ,விவேக் லால் ,ஆண்ட்ரூ ஒக்கொன்னோர் ,ஸ்காட் புஷ் ,அமித் ககர் ,சஞ்சய் சிங் ,மரக்கட்டை ஹோல்டிங்ஸ் ,ஹார்வர்ட் பல்கலைக்கழகம் ,நுரையீரல் ஆரோக்கியம் மையம் ,மொழிபெயர்ப்பு ஆராய்ச்சி ,நிர்வாகி துணை ப்ரெஸிடெஂட் ,வழக்கு நாளை மறுநாள் ,முக்கியமான பராமரிப்பு மருந்து ,தலைமை மருத்துவ ,தலைமை இயங்குகிறது ,